DE69419950D1 - Erythromycinderivate, ihr Verfahren zur Herstellung und ihre Verwendung als Arzneimittel - Google Patents

Erythromycinderivate, ihr Verfahren zur Herstellung und ihre Verwendung als Arzneimittel

Info

Publication number
DE69419950D1
DE69419950D1 DE69419950T DE69419950T DE69419950D1 DE 69419950 D1 DE69419950 D1 DE 69419950D1 DE 69419950 T DE69419950 T DE 69419950T DE 69419950 T DE69419950 T DE 69419950T DE 69419950 D1 DE69419950 D1 DE 69419950D1
Authority
DE
Germany
Prior art keywords
image
medicines
manufacturing process
erythromycin derivatives
radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69419950T
Other languages
English (en)
Other versions
DE69419950T2 (de
Inventor
Constantin Agouridas
Yannick Benedetti
Jean-Francois Chantot
Alexis Denis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Hoechst Marion Roussel
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel, Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel
Publication of DE69419950D1 publication Critical patent/DE69419950D1/de
Application granted granted Critical
Publication of DE69419950T2 publication Critical patent/DE69419950T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69419950T 1993-03-09 1994-03-08 Erythromycinderivate, ihr Verfahren zur Herstellung und ihre Verwendung als Arzneimittel Expired - Lifetime DE69419950T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9302674A FR2702480B1 (fr) 1993-03-09 1993-03-09 Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Publications (2)

Publication Number Publication Date
DE69419950D1 true DE69419950D1 (de) 1999-09-16
DE69419950T2 DE69419950T2 (de) 2000-01-13

Family

ID=9444766

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69419950T Expired - Lifetime DE69419950T2 (de) 1993-03-09 1994-03-08 Erythromycinderivate, ihr Verfahren zur Herstellung und ihre Verwendung als Arzneimittel

Country Status (23)

Country Link
US (1) US5439889A (de)
EP (1) EP0614905B1 (de)
JP (1) JP3228835B2 (de)
KR (1) KR100285972B1 (de)
CN (1) CN1040877C (de)
AT (1) ATE183190T1 (de)
AU (1) AU671708B2 (de)
BR (1) BR9400847A (de)
CA (1) CA2118564C (de)
DE (1) DE69419950T2 (de)
DK (1) DK0614905T3 (de)
ES (1) ES2135546T3 (de)
FI (1) FI110513B (de)
FR (1) FR2702480B1 (de)
GR (1) GR3031330T3 (de)
HU (1) HU219354B (de)
IL (1) IL108622A (de)
MA (1) MA23129A1 (de)
OA (1) OA09892A (de)
RU (1) RU2126803C1 (de)
TW (1) TW353661B (de)
UA (1) UA41871C2 (de)
ZA (1) ZA941610B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
GB9513756D0 (en) * 1995-07-06 1995-09-06 Smithkline Beecham Plc Novel process & compounds
NZ334274A (en) * 1996-09-04 2001-02-23 Abbott Lab 6-o-substituted ketolides having antibacterial activity
FR2760017B1 (fr) * 1997-02-27 1999-04-30 Hoechst Marion Roussel Inc Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
HUP0104192A3 (en) * 1998-11-03 2003-12-29 Pfizer Prod Inc Novel macrolide antibiotics
IL145739A0 (en) * 1999-05-24 2002-07-25 Pfizer Prod Inc 13-methyl-erythromycin derivatives
US6573409B1 (en) 1999-07-02 2003-06-03 The Nutrasweet Company Process for the preparation of 3,3-dimethylbutanal
WO2005007143A2 (en) * 2003-07-14 2005-01-27 The Board Of Trustees Of The University Of Illinois Use of makrolides and ketolides for the treatment of tuberculosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR487411A (fr) * 1916-03-06 1918-07-03 Henri Dreyfus Procédé pour la fabrication de l'aldéhyde acétique en partant de l'acétylène
FR2534588B2 (fr) * 1982-10-15 1985-09-20 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
EP0201166B1 (de) * 1985-03-12 1990-02-07 Beecham Group Plc Erythromycin-Derivate
PT86800B (pt) * 1987-02-24 1992-05-29 Beecham Group Plc Processo para a preparacao de derivados de eritromicina
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
CN1108259A (zh) 1995-09-13
AU5763994A (en) 1994-09-15
ZA941610B (en) 1995-03-24
HU9400679D0 (en) 1994-06-28
OA09892A (fr) 1994-09-15
TW353661B (en) 1999-03-01
ES2135546T3 (es) 1999-11-01
KR940021571A (ko) 1994-10-19
CA2118564A1 (fr) 1994-09-10
CA2118564C (fr) 2007-05-08
FR2702480B1 (fr) 1995-04-28
AU671708B2 (en) 1996-09-05
GR3031330T3 (en) 1999-12-31
UA41871C2 (uk) 2001-10-15
MA23129A1 (fr) 1994-10-01
EP0614905A1 (de) 1994-09-14
FI941094A (fi) 1994-09-10
HUT71472A (en) 1995-11-28
RU2126803C1 (ru) 1999-02-27
DE69419950T2 (de) 2000-01-13
CN1040877C (zh) 1998-11-25
BR9400847A (pt) 1994-11-01
DK0614905T3 (da) 2000-03-06
JP3228835B2 (ja) 2001-11-12
US5439889A (en) 1995-08-08
KR100285972B1 (ko) 2001-05-02
IL108622A0 (en) 1994-05-30
FI941094A0 (fi) 1994-03-08
FR2702480A1 (fr) 1994-09-16
IL108622A (en) 1999-08-17
JPH06321942A (ja) 1994-11-22
EP0614905B1 (de) 1999-08-11
HU219354B (en) 2001-03-28
ATE183190T1 (de) 1999-08-15
FI110513B (fi) 2003-02-14

Similar Documents

Publication Publication Date Title
DE69301897T2 (de) Erythromycinderivate, ihr Verfahren zur Herstellung und ihre Verwendung als Arzneimitteln
DE69416306D1 (de) Sphingoglycolipid und verwendung davon
BG100951A (en) Novel erythromycin derivatives, method for their preparation and their use as drugs
ATE205837T1 (de) Chinoxaline, verfahren zu ihrer herstellung und ihre verwendung
DE69419950T2 (de) Erythromycinderivate, ihr Verfahren zur Herstellung und ihre Verwendung als Arzneimittel
ATE155140T1 (de) 3-deoxyoligosacchariden, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE133938T1 (de) Indan-1,3-dion und indan-1,2,3-trionderivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung
DE59309756D1 (de) 4-Iminochinoline, Verfahren zu ihrer Herstellung und ihre Verwendung
YU25699A (sh) Novi derivati eritromicina, postupak za njihovu izradu i njihova primena
ATE170520T1 (de) Eburnan-derivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
AU6694290A (en) Synthesis of perfluoroalkyl bromides
HUT71797A (en) Cyclohexane derivatives, process for producing them and their use for the treatment of disease
AU1234488A (en) New 2-(2,3-dihydro-2-oxo-3-benzofuranyl) acetic acid derivatives, processes for preparing them and the pharmaceutical compositions which contain them
DE69904940D1 (de) 6-deoxy-erythromycin-derivate, ihrer herstellung, und ihrer verwendung als arzneimitteln
ATE53839T1 (de) 2,3-dihydro-3-phenyl-benzofuran-2-onacetamidderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DE59200413D1 (de) Buntesalzgruppen aufweisende Organosiliciumverbindungen, Verfahren zu ihrer Herstellung sowie ihre Verwendung.
DE69419083T2 (de) Salmycine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: AVENTIS PHARMA S.A., ANTONY CEDEX, FR

8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC